(Q40437209)

20 September 2017

title

Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death (English)

1 reference

20 September 2017

1 reference

Moehring A

1

1 reference

20 September 2017

Wohlbold L

series ordinal

2

1 reference

20 September 2017

Aulitzky WE

series ordinal

3

1 reference

20 September 2017

van der Kuip H

series ordinal

4

1 reference

20 September 2017

publication date

1 June 2005

1 reference

Cell Death & Differentiation

20 September 2017

published in

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

627-636

1 reference

The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

Poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

1 reference

7 January 2021

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Bcr/Abl expression stimulates integrin function in hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Imatinib mesylate (STI571) prevents the mutator phenotype of Bcr-Abl in hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Molecular characterization of mitochondrial apoptosis-inducing factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

DNA-binding properties of poly(ADP-ribose) polymerase: a target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

PARP goes transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Recombinant IFN-alpha2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Poly(ADP-ribosyl)ation inhibitors: promising drug candidates for a wide variety of pathophysiologic conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Role of ERK activation in growth and erythroid differentiation of K562 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Physiology and pathophysiology of poly(ADP-ribosyl)ation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Mitochondria, AIF and caspases--rivaling for cell death execution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Enhanced phosphorylation of p53 by ATM in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Phosphatidylinositol 3-kinase inhibitors, Wortmannin or LY294002, inhibited accumulation of p21 protein after gamma-irradiation by stabilization of the protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

The phosphoinositide 3-kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401608

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401608

1 reference

Dimensions Publication ID

20 September 2017

1028815640

0 references

1 reference